Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

NASDAQ:TALK - Nasdaq - US87427V1035 - Common Stock - Currency: USD

2.82  +0.06 (+2.17%)

After market: 2.8005 -0.02 (-0.69%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TALK. TALK was compared to 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for TALK as it has an excellent financial health rating, but there are worries on the profitability. TALK is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TALK was profitable.
TALK had a positive operating cash flow in the past year.
TALK had negative earnings in 4 of the past 5 years.
TALK had negative operating cash flow in 4 of the past 5 years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

TALK has a Return On Assets of 0.83%. This is comparable to the rest of the industry: TALK outperforms 49.02% of its industry peers.
TALK has a Return On Equity (0.98%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.83%
ROE 0.98%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Profit Margin, with a value of 0.61%, TALK is in line with its industry, outperforming 51.96% of the companies in the same industry.
The Gross Margin of TALK (45.76%) is better than 74.51% of its industry peers.
TALK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.61%
GM 45.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TALK has been increased compared to 1 year ago.
Compared to 5 years ago, TALK has more shares outstanding
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.60 indicates that TALK is not in any danger for bankruptcy at the moment.
TALK's Altman-Z score of 12.60 is amongst the best of the industry. TALK outperforms 94.12% of its industry peers.
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.6
ROIC/WACCN/A
WACC9.18%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.84 indicates that TALK has no problem at all paying its short term obligations.
The Current ratio of TALK (6.84) is better than 97.06% of its industry peers.
A Quick Ratio of 6.84 indicates that TALK has no problem at all paying its short term obligations.
TALK has a better Quick ratio (6.84) than 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 6.84
Quick Ratio 6.84
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

TALK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.00%, which is quite impressive.
Looking at the last year, TALK shows a very strong growth in Revenue. The Revenue has grown by 25.02%.
TALK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.48% yearly.
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)25.02%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%14.9%

3.2 Future

The Earnings Per Share is expected to grow by 166.23% on average over the next years. This is a very strong growth
Based on estimates for the next years, TALK will show a very strong growth in Revenue. The Revenue will grow by 21.05% on average per year.
EPS Next Y410%
EPS Next 2Y216.7%
EPS Next 3Y166.23%
EPS Next 5YN/A
Revenue Next Year19.44%
Revenue Next 2Y19.72%
Revenue Next 3Y20.48%
Revenue Next 5Y21.05%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

TALK is valuated quite expensively with a Price/Earnings ratio of 141.00.
The rest of the industry has a similar Price/Earnings ratio as TALK.
The average S&P500 Price/Earnings ratio is at 25.82. TALK is valued rather expensively when compared to this.
TALK is valuated quite expensively with a Price/Forward Earnings ratio of 28.12.
The rest of the industry has a similar Price/Forward Earnings ratio as TALK.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, TALK is valued a bit more expensive.
Industry RankSector Rank
PE 141
Fwd PE 28.12
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TALK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 75.87
EV/EBITDA N/A
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TALK's earnings are expected to grow with 166.23% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y216.7%
EPS Next 3Y166.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TALK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (5/23/2025, 7:57:07 PM)

After market: 2.8005 -0.02 (-0.69%)

2.82

+0.06 (+2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-04 2025-08-04/amc
Inst Owners60.1%
Inst Owner Change-4.2%
Ins Owners3.07%
Ins Owner Change4.06%
Market Cap475.00M
Analysts81.54
Price Target5.1 (80.85%)
Short Float %2.87%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)161.44%
Min EPS beat(2)30.72%
Max EPS beat(2)292.16%
EPS beat(4)3
Avg EPS beat(4)93.97%
Min EPS beat(4)-46.99%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)64.54%
EPS beat(12)10
Avg EPS beat(12)43.88%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-4.06%
Max Revenue beat(2)-2.13%
Revenue beat(4)1
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)0.06%
Revenue beat(8)5
Avg Revenue beat(8)1.97%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)3.46%
EPS NY rev (3m)-13.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-3.24%
Valuation
Industry RankSector Rank
PE 141
Fwd PE 28.12
P/S 2.53
P/FCF 75.87
P/OCF 40.58
P/B 4.05
P/tB 4.05
EV/EBITDA N/A
EPS(TTM)0.02
EY0.71%
EPS(NY)0.1
Fwd EY3.56%
FCF(TTM)0.04
FCFY1.32%
OCF(TTM)0.07
OCFY2.46%
SpS1.11
BVpS0.7
TBVpS0.7
PEG (NY)0.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 0.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.61%
GM 45.76%
FCFM 3.34%
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 633.64%
Cap/Sales 2.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 545.38%
Current Ratio 6.84
Quick Ratio 6.84
Altman-Z 12.6
F-Score8
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y410%
EPS Next 2Y216.7%
EPS Next 3Y166.23%
EPS Next 5YN/A
Revenue 1Y (TTM)25.02%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%14.9%
Revenue Next Year19.44%
Revenue Next 2Y19.72%
Revenue Next 3Y20.48%
Revenue Next 5Y21.05%
EBIT growth 1Y80.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year474.19%
EBIT Next 3Y140.87%
EBIT Next 5Y109.41%
FCF growth 1Y137.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y171.4%
OCF growth 3YN/A
OCF growth 5YN/A